Patient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study

Peer Review reports

Original Submission
6 Dec 2016	Submitted	Original manuscript
19 Jan 2017	Reviewed	Reviewer Report - Patricia Coyle
12 Apr 2017	Reviewed	Reviewer Report - Francesco Patti
16 May 2017	Author responded	Author comments - Frank A. Hoffmann
Resubmission - Version 2
16 May 2017	Submitted	Manuscript version 2
27 Jun 2017	Reviewed	Reviewer Report - Diane L. Cookfair
14 Jul 2017	Author responded	Author comments - Frank A. Hoffmann
Resubmission - Version 3
14 Jul 2017	Submitted	Manuscript version 3
Publishing
19 Jul 2017	Editorially accepted
9 Aug 2017	Article published	10.1186/s12883-017-0928-9

Back to article page